Compare GGT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GGT | TKNO |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.5M | 138.1M |
| IPO Year | N/A | 2021 |
| Metric | GGT | TKNO |
|---|---|---|
| Price | $4.34 | $5.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 286.7K | 130.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 0.83 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $5.18 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $3.75 | $1.91 |
| 52 Week High | $4.39 | $6.68 |
| Indicator | GGT | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 61.13 | 73.01 |
| Support Level | $4.11 | $4.79 |
| Resistance Level | $4.37 | $5.89 |
| Average True Range (ATR) | 0.06 | 0.40 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 83.33 | 72.08 |
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.